Evvy
Signal active
Organization
Contact Information
Overview
Evvy is a developer of at-home vaginal microbiome tests to close the gender health gap and improve female health. It uses metagenomic sequencing to understand symptoms and risks for critical health challenges, and get personalized reports.
About
Industries
Biotechnology, Health Care, Women's
Founded
2020
Employees
11-50
Headquarters locations
New York, New York, United States, North America
Social
N/A
Profile Resume
Evvy headquartered in New York, New York, United States, North America, operates in the Biotechnology, Health Care, Women's sector. The company focuses on Biotechnology and has secured $456.0M in funding across 24 round(s). With a team of 11-50 employees, Evvy is actively contributing to advancements in Biotechnology. Their latest funding round, Series A - Evvy, raised $14.0M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
2
Investors
8
Lead Investors
0
Total Funding Amount
$19.0M
Details
2
Evvy has raised a total of $19.0M in funding over 2 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2021 | Seed | 5.0M | ||
| 2023 | Early Stage Venture | 14.0M |
Investors
Evvy is funded by 21 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| LabCorp Venture Fund | - | FUNDING ROUND - LabCorp Venture Fund | 14.0M |
| Amboy Street Ventures | - | FUNDING ROUND - Amboy Street Ventures | 14.0M |
| Evvy | - | FUNDING ROUND - Evvy | 14.0M |
| RH Capital | - | FUNDING ROUND - RH Capital | 14.0M |
Recent Activity
There is no recent news or activity for this profile.